Back to Browse Journals » International Journal of Nanomedicine » Volume 9 » Issue 1
Stepwise encapsulation and controlled two-stage release system for cis-Diamminediiodoplatinum
Authors Chen Y, Li Q, Wu QS
Received 29 January 2014
Accepted for publication 9 April 2014
Published 28 June 2014 Volume 2014:9(1) Pages 3175—3182
DOI https://doi.org/10.2147/IJN.S61570
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Yun Chen,1,* Qian Li,1,2,* Qingsheng Wu1
1Department of Chemistry, Key Laboratory of Yangtze River Water Environment, Ministry of Education, Tongji University, Shanghai; 2Shanghai Institute of Quality Inspection and Technical Research, Shanghai, People’s Republic of China
*These authors contributed equally to this work
Abstract: cis-Diamminediiodoplatinum (cis-DIDP) is a cisplatin-like anticancer drug with higher anticancer activity, but lower stability and price than cisplatin. In this study, a cis-DIDP carrier system based on micro-sized stearic acid was prepared by an emulsion solvent evaporation method. The maximum drug loading capacity of cis-DIDP-loaded solid lipid nanoparticles was 22.03%, and their encapsulation efficiency was 97.24%. In vitro drug release in phosphate-buffered saline (pH =7.4) at 37.5°C exhibited a unique two-stage process, which could prove beneficial for patients with tumors and malignancies. MTT (3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide) assay results showed that cis-DIDP released from cis-DIDP-loaded solid lipid nanoparticles had better inhibition activity than cis-DIDP that had not been loaded.
Keywords: stearic acid, emulsion solvent evaporation method, drug delivery, cis-DIDP, in vitro
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Readers of this article also read:
Molecular targets in arthritis and recent trends in nanotherapy
Roy K, Kanwar RK, Kanwar JR
International Journal of Nanomedicine 2015, 10:5407-5420
Published Date: 26 August 2015
Clinical diagnosis and management in early Huntington's disease: a review
Schiefer J, Werner CJ, Reetz K
Degenerative Neurological and Neuromuscular Disease 2015, 5:37-50
Published Date: 25 March 2015
Design real-time reversal of tumor multidrug resistance cleverly with shortened carbon nanotubes
Wu P, Li S, Zhang H
Drug Design, Development and Therapy 2014, 8:2431-2438
Published Date: 5 December 2014
Is increasing the dose of Entecavir effective in partial virological responders?
Erturk A, Adnan Akdogan R, Parlak E, Cure E, Cumhur Cure M, Ozturk C
Drug Design, Development and Therapy 2014, 8:621-625
Published Date: 29 May 2014
Relapsed Hodgkin lymphoma in adolescents: focus on current high-dose chemotherapy and autologous stem cell transplant
Guilcher GM, Stewart DA
Clinical Oncology in Adolescents and Young Adults 2014, 4:1-12
Published Date: 8 May 2014
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia
Soosay Raj TA, Smith AM, Moore AS
International Journal of Nanomedicine 2013, 8:4361-4369
Published Date: 6 November 2013
Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer
Shi J, Wang Z, Wang L, Wang H, Li L, Yu X, Zhang J, Ma R, Zhang Z
International Journal of Nanomedicine 2013, 8:1551-1562
Published Date: 19 April 2013
Controlled-release approaches towards the chemotherapy of tuberculosis
Saifullah B, Hussein MZ, Hussein Al Ali SH
International Journal of Nanomedicine 2012, 7:5451-5463
Published Date: 12 October 2012
True story about HIV: theory of viral sequestration and reserve infection
Barasa S
HIV/AIDS - Research and Palliative Care 2011, 3:125-133
Published Date: 8 December 2011
Current and developing therapeutic agents in the treatment of Chagas disease
Werner Apt
Drug Design, Development and Therapy 2010, 4:243-253
Published Date: 17 September 2010
